
A department adrift from its own “Gold” standards
Phantom citations, misinformation, and imbalance in HHS communications

HHS explains new vaccine recommendations: Is this the “gold standard science” we were promised?
FAQ sent to Congress looks more like fake gold

Rethinking Medications: Truth, Power, and the Drugs You Take
A critical appraisal of the state of the prescription medications in the United States

The tragic termination of the Diabetes Prevention Program Outcomes Study
An invaluable resource is being starved to death with no scientific or ethical justification

The use of placebo controls in clinical trials
Why the value of placebo controls is not an affirmation of a powerful placebo effect

Indiscriminate, Cruel, and Wasteful: Abandoning USAID clinical trials
The chaos and cruelty of its abrupt deconstruction are self-evident and already demonstrable

Botulinum Toxin: A tale of medicine, beauty, and danger
When used responsibly botulinum toxin is very safe, but patients should be especially vigilant about cosmetic treatments done outside a medical setting.

Pegcetacoplan (Syfovre™) for macular degeneration: an update
SBM's guest contributor and ophthalmologist, Dr. David Weinberg, provides an update on the phase 3 trials of pegcetacoplan for macular degeneration. The results are still disappointing.

Pegcetacoplan, a new treatment for macular degeneration
FDA approves a new treatment for macular degeneration: the good, the bad, and the disappointing.
We are not antivaccine, we are pro unattainable vaccine
When it comes to vaccines: “If it exists we resist.”